Open Access
Numéro
OCL
Volume 23, Numéro 1, January-February 2016
Numéro d'article D111
Nombre de pages 5
Section Dossier: Lipids and Brain / Lipides et cerveau
DOI https://doi.org/10.1051/ocl/2015022
Publié en ligne 17 juin 2015
  • Anil E. 2007. The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype. Proc. Nutr. Soc. 66: 60–68. [CrossRef] [PubMed] [Google Scholar]
  • Barberger-Gateau P, Lambert JC, Feart C, et al. 2013. From genetics to dietetics: the contribution of epidemiology to understanding Alzheimer’s disease. J. Alzheimers. Dis. 33: S457–S463. [PubMed] [Google Scholar]
  • Barberger Gateau P, Feart C, Samieri C, Letenneur L. Dietary patterns and dementia. In: Chronic Medical Disease and Cognitive Aging: Toward a Healthy Body and Brain, Yaffe K, ed. New York, Oxford University Press, 2013. [Google Scholar]
  • Barberger Gateau P, Samieri C, Feart C, Cunnane S. 2013. Acides gras oméga-3 et déclin cognitif : la controverse. OCL 20: 88–92. [CrossRef] [EDP Sciences] [Google Scholar]
  • Barberger Gateau P, Feart C, Samieri C. 2011. Mediterranean diet and cognitive decline: what role for omega-3 polyunsaturated fatty acids? OCL 18: 224–227. [EDP Sciences] [Google Scholar]
  • Barberger Gateau P, Samieri C, Feart C, Plourde M. 2011. Dietary omega 3 polyunsaturated fatty acids and Alzheimer’s disease: Interaction with apolipoprotein E genotype. Curr. Alzheimer. Res. 8: 479–491. [Google Scholar]
  • Barberger-Gateau P, Raffaitin C, Letenneur L, et al. 2007. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69: 1921–1930. [CrossRef] [PubMed] [Google Scholar]
  • Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. 2007. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am. J. Clin Nutr. 85: 1103–1111. [PubMed] [Google Scholar]
  • Carvalho-Wells AL, Jackson KG, Lockyer S, Lovegrove JA, Minihane AM. 2012. APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. Am. J. Clin. Nutr. 96: 1447–1453. [CrossRef] [PubMed] [Google Scholar]
  • Carvalho-Wells AL, Jackson KG, Gill R, et al. 2010. Interactions between age and apoE genotype on fasting and postprandial triglycerides levels. Atherosclerosis 212: 481–487. [Google Scholar]
  • Chouinard-Watkins R, Plourde M. 2014. Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? Nutrients 6: 4452–4471. [CrossRef] [PubMed] [Google Scholar]
  • Chouinard-Watkins R, Rioux-Perreault C, Fortier M, et al. 2013. Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE epsilon4 allele. Br. J. Nutr. 1–9. [Google Scholar]
  • Cummings JL. 2004. Alzheimer’s Disease. N. Engl. J. Med. 351: 56–67. [CrossRef] [PubMed] [Google Scholar]
  • Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. 2009. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog. Lipid Res. 48: 239–256. [CrossRef] [Google Scholar]
  • Farrer LAP, Cupples LAP, Haines JLP, et al. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 278: 1349–1356. [Google Scholar]
  • Genin E, Hannequin D, Wallon D, et al. 2011. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16: 903–907. [CrossRef] [PubMed] [Google Scholar]
  • Hennebelle M, Plourde M, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P, Cunnane SC. 2014. Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline. Proc. Nutr. Soc. 73: 80–86. [CrossRef] [PubMed] [Google Scholar]
  • Huang TL, Zandi PP, Tucker KL, et al. 2005. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon 4. Neurology 65: 1409–1414. [CrossRef] [PubMed] [Google Scholar]
  • Jiao J, Li Q, Chu J, Zeng W, Yang M, Zhu S. 2014. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 100: 1422–1436. [CrossRef] [PubMed] [Google Scholar]
  • Jofre-Monseny L, Minihane AM, Rimbach G. 2008. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 52: 131–145. [Google Scholar]
  • Lambert J-C, Amouyel P. 2011. Genetics of Alzheimer’s disease: new evidences for an old hypothesis? Curr. Opin. Genet. Dev. 21: 295–301. [CrossRef] [PubMed] [Google Scholar]
  • Lane RM, Farlow MR. 2005. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer’s disease. J. Lipid Res. 46: 949–968. [Google Scholar]
  • Plourde M, Vohl M-C, Vandal M, Couture P, Lemieux S, Cunnane SC. 2009. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE 4 but not by the common PPAR-alpha L162V polymorphism in men. Br. J. Nutr. 102: 1121–1124. [CrossRef] [PubMed] [Google Scholar]
  • Poirier J. 2003. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer’s disease. Trends Mol. Med. 9: 94–101. [CrossRef] [PubMed] [Google Scholar]
  • Querfurth HW, LaFerla FM. 2010. Alzheimer’s Disease. N. Engl. J. Med. 362: 329–344. [Google Scholar]
  • Quinn JF, Raman R, Thomas RG, et al. 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304: 1903–1911. [CrossRef] [PubMed] [Google Scholar]
  • Samieri C, Lorrain S, Buaud B, et al. 2013. Relationship between diet and plasma long-chain n-3 PUFA in older people:Impact of Apolipoprotein E genotype. J. Lipid Res. 54: 2559–2567. [CrossRef] [PubMed] [Google Scholar]
  • Samieri C, Feart C, Proust-Lima C, et al. 2011. Omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression. Neurobiol. Aging. 32: 2317.e13–22. [Google Scholar]
  • Shobab LA, Hsiung G-YR, Feldman HH. 2005. Cholesterol in Alzheimer’s disease. Lancet. Neurol. 4: 841–852. [Google Scholar]
  • Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. 2009. Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later. Dement. Geriatr. Cogn. Disord. 28: 75–80. [CrossRef] [PubMed] [Google Scholar]
  • Stonehouse W, Conlon CA, Podd J, et al. 2013. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am. J. Clin. Nutr. 97: 1134–1143. [CrossRef] [PubMed] [Google Scholar]
  • Van de Rest O, Geleijnse JM, Kok FJP, et al. 2008. Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology 71: 430–438. [CrossRef] [PubMed] [Google Scholar]
  • Whalley LJ, Deary IJ, Starr JM, et al. 2008. n-3 Fatty acid erythrocyte membrane content, APOE epsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am. J. Clin. Nutr. 87: 449–454. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.